Search results - 3 results

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

countries recover from COVID-19, these findings can help refocus efforts aimed at HCV  elimination. FUNDING: John C Martin Foundation, Gilead Sciences, AbbVie, ZeShan Foundation, and The Hepatitis Fund. ...

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

comparable to many surrounding countries. These adjusted prevalences can help estimate the cost of reimbursement of DAA s and invite Belgian policy makers to accelerate the scaling up of reimbursement, giving ...

Distribution of HCV genotypes in Belgium from 2008 to 2015.

CONCLUSION: This national monitoring study allowed a clear and objective view of the circulating HCV genotypes in Belgium and will help health authorities in the establishment of cost effectiveness ...

QR code

QR code for this page URL